6Ogata K,Nskamura K,Yokose N,et al.Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome[J].Blood,2002,100(12):3887-3896.
7Auberger J,Dlaska M,Auberger T,et al.Increased CD133 expression in bone marrow of myelodysplastic syndromes[J].Leuk Res,2005,29(9):995-1001.
8Stetler-Stevenson M,Arthur DC,Jabbour N,et al.Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome[J].Blood,2001,98(4):979-987.
9Valent P,Homy HP,Bennett JM,et al.Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes:Consensus statements and report from a working conference[J].Leuk Res,2007,31 (6):727-736.
